Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is a common genetic disorder affecting around 400 million people worldwide. Rapid diagnosis using the FINDER G6PD test ensures timely intervention, improving patient outcomes and saving healthcare resources and healthcare costs.
Any Test. Anywhere. Everyone.™
FINDER® Near-Patient Testing Platform for G6PD Deficiency
FDA-cleared and CE-marked FINDER G6PD test provides glucose 6-phosphate dehydrogenase enzymatic activity in whole blood specimens using only a 50 microliter sample, enabling clinicians to quickly and accurately determine G6PDd status.
FINDER G6PD Test
Rapid time to result of ≅ 17 minutes
Simple workflow with no sample preparation
Lab-equivalent performance of <5% CV
Small footprint – the size of an A4 sheet of paper.
FINDER G6PD Test is CE-marked and US FDA cleared.
*Latest Model of FINDER is not available for sale or use in any territory.
It has made a difference in the practice at our hospital. The ability to get a quantitative or semiquantitative value within 24 hours has made a difference in patient care, we really do appreciate this instrument.
Director, Hematology & Coagulation Laboratory
Baebies pricing structure and its technology platform were the primary drivers for pursuing the FINDER device.